Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.83B |
| 2 |
Wells Fargo
WFC
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Home Depot
HD
|
+$247M |
| 5 |
Alibaba
BABA
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$414M |
| 2 |
Lowe's Companies
LOW
|
+$326M |
| 3 |
Las Vegas Sands
LVS
|
+$265M |
| 4 |
AABA
Altaba Inc
AABA
|
+$249M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.65% |
| 2 | Technology | 8.5% |
| 3 | Financials | 8.48% |
| 4 | Consumer Discretionary | 7.65% |
| 5 | Industrials | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
State Street SPDR S&P Regional Banking ETF
KRE
$4.51B
| $1.21M | ﹤0.01% |
20,848
-416,781
| -95% | -$23.1M |
|
2877
PUT
Plains All American Pipeline
PAA
$17.6B
| $1.21M | ﹤0.01% |
+66,000
| New | +$1.21M |
|
2878
Globant
GLOB
$1.65B
| $1.21M | ﹤0.01% |
11,438
-26,286
| -70% | -$2.62M |
|
2879
Alpha Metallurgical Resources
AMR
$1.77B
| $1.21M | ﹤0.01% |
+133,833
| New | +$2.04M |
|
|
SILK
2880
CALL
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.21M | ﹤0.01% |
+30,000
| New | +$1.05M |
|
2881
PUT
Humana
HUM
$43.9B
| $1.21M | ﹤0.01% |
3,300
-200
| -6% | -$63.4K |
|
2882
Xeris Biopharma Holdings
XERS
$1.45B
| $1.21M | ﹤0.01% |
171,460
+77,982
| +83% | +$644K |
|
2883
HUTCHMED
HCM
$1.96B
| $1.21M | ﹤0.01% |
48,093
+19,856
| +70% | +$435K |
|
|
ETRN
2884
CALL
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $1.2M | ﹤0.01% |
90,000
| – | – |
|
|
OTIC
2885
DELISTED
Otonomy, Inc.
OTIC
| $1.2M | ﹤0.01% |
313,868
+295,753
| +1,633% | +$722K |
|
2886
Danaos Corp
DAC
$2.52B
| $1.2M | ﹤0.01% |
+130,790
| New | +$1.26M |
|
2887
Emergent Biosolutions
EBS
$379M
| $1.2M | ﹤0.01% |
22,261
-352,248
| -94% | -$19.1M |
|
2888
Cato Corp
CATO
$65.7M
| $1.2M | ﹤0.01% |
68,964
-81,919
| -54% | -$1.47M |
|
|
NBL
2889
DELISTED
Noble Energy, Inc.
NBL
| $1.2M | ﹤0.01% |
48,266
-8,530,392
| -99% | -$181M |
|
|
HARP
2890
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $1.2M | ﹤0.01% |
+8,102
| New | +$1.23M |
|
|
GREK
2891
Global X MSCI Greece ETF
GREK
$293M
| $1.2M | ﹤0.01% |
+39,318
| New | +$1.15M |
|
2892
Varex Imaging
VREX
$462M
| $1.19M | ﹤0.01% |
40,028
-7,197
| -15% | -$215K |
|
|
TSC
2893
DELISTED
TriState Capital Holdings, Inc.
TSC
| $1.19M | ﹤0.01% |
+45,655
| New | +$1.09M |
|
|
USCR
2894
DELISTED
U S Concrete, Inc.
USCR
| $1.19M | ﹤0.01% |
28,601
-17,267
| -38% | -$790K |
|
2895
PUT
PG&E
PCG
$39B
| $1.19M | ﹤0.01% |
+109,500
| New | +$938K |
|
2896
Oxford Square Capital
OXSQ
$150M
| $1.19M | ﹤0.01% |
218,411
+201,644
| +1,203% | +$1.11M |
|
2897
CALL
Williams Companies
WMB
$85.8B
| $1.19M | ﹤0.01% |
50,000
+40,000
| +400% | +$916K |
|
2898
CALL
AnaptysBio
ANAB
$1.54B
| $1.19M | ﹤0.01% |
72,900
-390,000
| -84% | -$9.22M |
|
2899
CALL
Elanco Animal Health
ELAN
$13.2B
| $1.18M | ﹤0.01% |
+40,000
| New | +$1.09M |
|
2900
PUT
Globus Medical
GMED
$11.1B
| $1.18M | ﹤0.01% |
+20,000
| New | +$1.09M |
|
Similar funds
Millennium Management's Q4 2019 Portfolio in Review
As of Q4 2019, Millennium Management held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Millennium Management deployed $9.74B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.
By sector, the portfolio is most concentrated in Healthcare at 9.7% of assets, down from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.
- Millennium Management's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
- Millennium Management's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
- Millennium Management fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
- Millennium Management's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
- Millennium Management opened 829 new positions and closed 796 in Q4 2019.
- Millennium Management's portfolio value rose 26% quarter-over-quarter to $79.9B.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.